Dr. Mikhael on Unanswered Questions in CAR-T | Blood Cancers Today
Among the major dilemmas persisting in CAR-T therapy use is how to balance malignancy risks.
Among the major dilemmas persisting in CAR-T therapy use is how to balance malignancy risks.
Survey results suggest that cancer patients want financial toxicity screening to occur early, but screening preferences and practices vary.
An abstract is unavailable.
Eric Kumar Singhi, MD, discusses the current therapeutic landscape and unmet needs in small cell and non–small cell lung cancer.
Acute Myeloid Leukemia is a type of blood cancer that occurs in the blood and bone marrow.
Rates of treatment-related adverse events were similar between the treatment arms.
Mark Ronson performs Nothing Breaks Like A Heart ft Miley Cyrus in the BBC Radio 1 Live Loungehttp://vevo.ly/c6hCVY#MarkRonson #NothingBreaksLikeAHeart #Vevo…
The 12th International Workshop on Waldenstrom’s Macroglobulinemia (IWWM-12) took place in Prague, Czech Republic. This meeting brought together leading experts to discuss the latest advances…
Britain’s departure from the European Union cost London’s financial centre about 40,000 jobs, the Lord Mayor of the City of London told Reuters, a far…
“Treatment effectiveness can have different meanings to patients,” a physician assistant said when discussing therapy for high-risk myeloma.
During a Case-Based Roundtable® event, Ursa Brown-Glaberman, MD, discussed options for the treatment of patients with PIK3CA-altered metastatic breast cancer.